drugset / Trial / NCT02182661

A Long-term Study of Ba253BINEB in Patients With Bronchial Asthma

NCT02182661 ↗

Phase 3 Completed 88 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to investigate the long-term safety of Ba253BINEB. Secondarily the long-term efficacy of Ba253BINEB is also investigated.

Timeline

Start
1998-07
Primary completion
2000-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Ba253BINEB Unknown — —

Indications